Companies can make generic Ozempic as of next week, but don’t expect to get it soon
TORONTO — Drug companies in Canada are allowed to make lower priced generic versions of the blockbuster drug…
Here’s where the deadly fungus is spreading
(NEXSTAR) – Hospitals, nursing homes and other medical facilities are struggling to gain ground on a drug-resistant and…
Corcept Receives Complete Response Letter for Relacorilant as a Treatment for Patients with Hypercortisolism
REDWOOD CITY, Calif., December 31, 2025–(BUSINESS WIRE)–Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery…
Superbug hits 27 states: Here’s where the deadly fungus is spreading
(NEXSTAR) – Hospitals, nursing homes and other medical facilities are struggling to gain ground on a drug-resistant and…
Billionaire Mark Cuban Wants U.S. Healthcare To Go Back To 1955. Doctors Provide Care, Patients Get A Bill —’And If They Can Afford It, They Pay’
Healthcare didn’t become confusing overnight. It got there slowly, buried under paperwork, billing codes, and middlemen most patients…
Eli Lilly’s pill solves the biggest problem with weight loss
Losing weight hasn’t quite been the hardest part of modern obesity treatment. Keeping it off is. That’s exactly…
‘How I knew I had ovarian cancer’: Survivors and caregiver discuss symptoms
Bloating, diarrhea and abdominal pain are three of the most common symptoms of ovarian cancer. They’re also some…
people waiting 96 hours and you may have to wear a mask in the UK
The UGT Sanidad health union has warned of the ‘serious’ situation of “saturation” in the emergency department at…
Oh no, Ozempic! Eli Lilly’s New Weight-Loss Drug KOs Rival Treatments
How do you swear in Danish? Our AI chatbots are much too polite to help us out here,…
TGA’s major health warning for popular weight loss drugs including Ozempic, Wegovy and Mounjaro: ‘Suicidal thoughts’
The Australian Therapeutic Goods Administration (TGA) has updated and aligned safety warnings for people using GLP-1 and dual…
MannKind Announces U.S. FDA Accepts for Review its Supplemental New Drug Application (sNDA) of FUROSCIX ReadyFlow™ Autoinjector for the Treatment of Edema in Adults with Chronic Heart Failure or Chronic Kidney Disease
MannKind If approved, ReadyFlow Autoinjector would deliver an IV-equivalent diuretic dose (subcutaneous furosemide injection 80 mg/ml) in under…
Trump admin claims win as UK bows to pressure on NHS drug spending – POLITICO
The NICE threshold will rise to £25,000 to £35,000 for every quality adjusted life year. In return for…